SB 15 Delaware Senate · 150th General Assembly (2019-2020)

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE PROVISION OF INFORMATION ABOUT LYME DISEASE.

Summary
This Act, modeled on similar laws in Virginia and Maryland, requires a health-care provider to provide notice to a patient at the time blood is drawn to perform a laboratory test for Lyme disease that explains the limitations of the test and instructs the patient to see their health-care provider if the patient continues to experience unexplained symptoms. This Act is consumer and patient friendly.
Bill status signed all 5 stages cleared
Introduction
Jan 2019
Committee Review
May 2019
Senate Passage
May 2019
House Passage
May 2019
Signed into Law
Aug 2019
Introduced Jan 24, 2019 Signed Aug 21, 2019
Floor votes · House May 16, 2019

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
8
Key actions
6
Committee
2
Amendments
1
Aug 21, 2019
Signed into law
Signed by Governor
executive
May 16, 2019
Lower · Passed
Passed By House. Votes: 40 YES 1 NO
lower
May 15, 2019
Lower · Passed
Reported Out of Committee (Health & Human Development) in House with 2 Favorable, 5 On Its Merits
lower
May 8, 2019
Introduced
Assigned to Health & Human Development Committee in House
lower
May 7, 2019
Upper · Passed
Passed By Senate. Votes: 21 YES
upper
May 7, 2019
Upper · Passed
Amendment SA 1 to SB 15 - Passed By Senate. Votes: 20 YES 1 ABSENT
upper
Apr 17, 2019
Upper · Passed
Reported Out of Committee (Health & Social Services) in Senate with 2 Favorable, 2 On Its Merits
upper
Jan 24, 2019
Introduced
Introduced and Assigned to Health & Social Services Committee in Senate
upper
3 primary · 22 co-sponsors

Sponsors